Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use

Brain Research

Volumn 496, Issue 1-2, 1989, Pages 268-284

  Kurumaji, Akeo ^a   Nehls, Daniel G ^a   Chun Kun Park, ^a   McCulloch, James ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

3 (2 Carboxypiperazin 4 yl) propyl 1 phosphonic acid; Autoradiography; Cerebral glucose utilisation; Deoxy sugar; MK 801; N Methyl D aspartate receptor

Indexed keywords

4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; DEOXYGLUCOSE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RADIOISOTOPE;

ANIMAL CELL; ANIMAL EXPERIMENT; AUTORADIOGRAPHY; BRAIN REGION; GLUCOSE UTILIZATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; BRAIN; DEOXY SUGARS; DEOXYGLUCOSE; DIBENZOCYCLOHEPTENES; DIZOCILPINE MALEATE; MALE; PIPERAZINES; RATS; RATS, INBRED STRAINS; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NEUROTRANSMITTER; SUPPORT, NON-U.S. GOV'T;

EID: 0024396066     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(89)91074-3     Document Type: Article

References (75)

1. 3H-catecholamines
2. Hippocampal region
3. Convergent thalamic and mesencephalic projections to the anterior medial cortev in the rat
4. The N-methyl-D-aspartate antagonists, CGS 19755 and CPP reduce ischemic brain damage in gerbils
5. 3H]-MK-801 binding sites in mammalian brain
6. Specific release of endogenous glutamate from piriform cortex stimulated in vitro
7. Ifenprodil and SL 82.0715 as cerebral anti-ischaemic agents. II. Evidence for NMDA receptor antagonist properties
8. Anticonvulsant activity of (+)-5-methyl-10, 11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties
9. Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties
10. Restoration of shock-suppressed behavior by treatment with (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central asympathomimetic, and apparent anxiolytic properties
11. NMDA receptors—their role in long-term potentiation
12. Release of endogenous amino acid neurotransmitter candidates from rat olfactory slices: possible regulatory mechanisms and the effects of pentobarbitone
13. The N-methyl-D-aspartate antagonist, 2-amino-7-phosphonoheptanoate, produces phencyclidinelike behavioral effects in rats
14. Excitatory amino acids in the brain—focus on NMDA receptors
15. Local changes in cerebral glucose utilization during ketamine anesthesia
16. Effects of the GABA receptor agonist, progabide, upon local cerebral glucose utilization
17. Dual component amino-acid-mediated synaptic potentials: excitatory drive for swimming in xenopus embryos
18. Glucose utilization in the Papez circuit: effects of oxotremorine and scopolamine
19. 3H]D-AP5 binding sites on brain membranes and anticonvulsant activity
20. Projection from the cingulate cortex in the rat
21. Neurophysiology of limbic system pathways in the rat: projections form the subicular complex and hippocampus to the entorhinal cortex
22. Systemic administration of MK-801 prevents N-methyl-D-aspartate-induced neuronal degeneration in rat brain
23. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain
24. Systemic administration of MK-protects againts ischemia-induced hippocampal neurodegeneration in the gerbil
25. The effects of apomorphine upon local cerebral glucose utilization in conscious rats and in rats anesthetized with chloral hydrate
26. Unitary analysis of opossum prepyriform cortex
27. Altered metabolic activity in the cerebral cortex of rats exposed to ketamine
28. Laminar organisation of thalamic projections to the rat neocortex
29. Effects of excitatory amino acids and their antagonists on membrane and action potentials of cat caudate neurones
30. 3H]TCP binding sites
31. Complex synaptic responses of entorhinal cortical cells in the rat to subicular stimulation in vitro; demostration of an NMDA receptor-mediated component
32. Effects of the putative GABAergic agonists, muscimol and THIP, upon local cerebral glucose utilization
33. Noncompetitive antagonists of excitatory amino acid receptors
34. A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats
35. MK-801, a proposed non-competitive antagonist of excitatory amino acid neurotransmission, produced phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys
36. Intrinsic projections of the retrohippocampal region in the rat brain. I. The subicular complex
37. Effects of δ agonist compounds on local cerebral glucose utilization: relationship to psychotomimetic properties
38. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo
39. NMDA receptor activation and early olfactory learning
40. Different patterns of cerebral glucose utilization produced by phenyclidineand d-N-allynormetazocine
41. 3H]2deoxy-D-glucose capture in the hippocampus and dentate gyrus of ketamine-anesthetized rat
42. 3H-TCP-labeled receptors in rat brain
43. Localization of phencyclidine-induced changes in brain energy metabolism
44. 14C]deoxyglucose
45. The distribution of alterations in energy metabolism in the rat produced by apomorphine
46. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters
47. 3H]glutamate-binding sites in rat brain
48. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-asparte receptor antagonist, AP5
49. 3H]3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors
50. Effects of acute administration of caffeine on local cerebral glucose utilization in the rat
51. Differential effects of competitive and non-competitive N-methyl-D-asparte antagonists on glucose use in the limbic system
52. The influence of droperidol, diazepam and physostigmine on ketamine-inducedbehavior and brain regional glucose utilization in rat
53. Comparative effects of acute and chronic administration of amphetamine on local cerebral glucose utilization in the conscious rat
54. Protective effect of the glutamate antagonist, MK-801, in focal cerebral ischemia in the cat
55. A proposed mechanism of emotion
56. Glutamic acid as a putative transmitter of the interhemispheric corticocortical connections in the rat
57. Correlation of dose-dependent effects of acute amphetamine administration on behaviour and local cerebral metabolism in rats
58. Electrical activity observed in guinea-pig olfactory cortex in vitro
59. Local cerebral glucose consumption in the rat. I. Effects of halothane anesthesia
60. Blockade of N-methyl-D-aspartate receptors may protect againts ishemic damage in the brain
61. Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release
62. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization and anesthetized albino rat
63. Amino acids as neurotransmitters of corticofugal neurones in the rat: a comparison of glutamate and aspartate
64. Olfactory system
65. PCP-induced alterations in cerebral glucose utilization in rat brain: blockade by metaphit, a PCP-receptor-acylating agent
66. Both competitive and non-competitive antagonists of N-methyl-D-aspartic acid discrupt brightness discrimination in rats
67. A magnesium-sensitive post-synaptic potential in rat cerebral cortex resembles neuronal responses to N-methylaspartate
68. Muscle relaxant and anticonvulsant activity of 3-((±)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, anovel N-methyl-d-aspartate in rodents
69. Effects ofd- andl-amphetamine on local cerebral glucose utilization in the conscious rat
70. Alterations in local cerebral glucose utilization induced by phencyclidine
71. Glutamate as transmitter of hippocampal perforant path
72. Hypoglycemia-induced neuronal damage prevented by an N-methyl-d-aspartate antagonist
73. The anticonvulsant MK-801 is a potent N-methyl-d-aspartate antagonist
74. 3H]MK-801 labels a site on the N-methyl-d-aspartate receptor channel complex in rat brain membranes